Institutional
27 de July de 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
27 de October de 2025
Legal 500 recognizes Kasznar Leonardos as Leading Firm in Latin America
We are honored to announce that our partners Gabriel Leonardos, Elisabeth Kasznar, and Rafael Lacaz have been recognized as Leading Partners by … Legal 500 recognizes Kasznar Leonardos as Leading Firm in Latin America
23 de October de 2025
Kasznar Leonardos partners are ranked as IAM Global Leaders 2026
We are proud to announce that our partners Gabriel Leonardos and Tatiana Silveira have been recognized as IAM Global Leaders 2026! Each … Kasznar Leonardos partners are ranked as IAM Global Leaders 2026
22 de October de 2025
Elisabeth Kasznar is recognized as Trademarks Lawyer of the Year by Lexology Index Awards
We are proud to announce that our partner Elisabeth Kasznar has been recognized as IP – Trademarks Lawyer of the Year by … Elisabeth Kasznar is recognized as Trademarks Lawyer of the Year by Lexology Index Awards